Cannabinoid receptor 1 regulates ERK and GSK-3β-dependent glucocorticoid inhibition of osteoblast differentiation in murine MC3T3-E1 cells

Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis

Kenneth G. Saag, Elizabeth Shane, Steven Boonen et al. · New England Journal of Medicine · 2007 · 908 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

David M. Reid, Jean‐Pierre Devogelaer, Kenneth G. Saag et al. · The Lancet · 2009 · 529 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +12

Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid Receptor

Alexander Rauch, Sebastian Seitz, Ulrike Baschant et al. · Cell Metabolism · 2010 · 422 citations

Medicine, Endocrinology, Bone Metabolism +13

Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by β-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT

Maria Almeida, Han Li, Teresita Bellido et al. · Journal of Biological Chemistry · 2005 · 397 citations · Full text

Life Sciences, Cell Biology, Apoptosis +15

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

Aymen I. Idris, Rob vanʼt Hof, Iain R. Greig et al. · Nature Medicine · 2005 · 351 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16